Literature DB >> 214572

Differential sensitivity of normal and transformed human cells to reovirus infection.

M R Duncan, S M Stanish, D C Cox.   

Abstract

Normal and simian virus 40-transformed WI-38 cells exhibited a differential sensitivity to infection with type 3 reovirus. A progressive decrease in viability began 24 to 36 h after infection of transformed cells terminating in complete lysis of cultures by 96 h. Normal cells were productively infected and continued to produce and release virus for as long as 14 days after infection, but exhibited no detectable cytopathology. Inhibition of cellular DNA synthesis began 15 to 18 h after infection in transformed cells before development of cytopathology. No inhibition of DNA synthesis was detected in infected normal cells. No significant differences were noted in the adsorption or early replication characteristics of reovirus in normal and transformed cells. Virus replication and host cell DNA synthesis in normal and transformed human cells were compared to reovirus-infected L-929 mouse fibroblast cells.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 214572      PMCID: PMC354293     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  15 in total

1.  Persistent infections in L cells with temperature-sensitive mutants of reovirus.

Authors:  R Ahmed; A F Graham
Journal:  J Virol       Date:  1977-08       Impact factor: 5.103

2.  Initiation of DNA replication in mammalian cells and its inhibition by reovirus infection.

Authors:  R Hand; I Tamm
Journal:  J Mol Biol       Date:  1974-01-15       Impact factor: 5.469

3.  Cellular DNA and protein synthesis in reovirus-infected L cells.

Authors:  W D Ensminger; I Tamm
Journal:  Virology       Date:  1969-10       Impact factor: 3.616

4.  Polypeptide components of virions, top component and cores of reovirus type 3.

Authors:  R E Smith; H J Zweerink; W K Joklik
Journal:  Virology       Date:  1969-12       Impact factor: 3.616

5.  SV40 transformation of human diploid cells. A parallel study of viral and karyologic parameters.

Authors:  A J Girardi; D Weinstein; P S Moorhead
Journal:  Ann Med Exp Biol Fenn       Date:  1966

6.  Early inhibition of cellular DNA synthesis by high multiplicities of infectious and UV-inactivated Reovirus.

Authors:  J E Shaw; D C Cox
Journal:  J Virol       Date:  1973-10       Impact factor: 5.103

7.  Inhibition of the initiation of cellular DNA synthesis after reovirus infection.

Authors:  D C Cox; J E Shaw
Journal:  J Virol       Date:  1974-03       Impact factor: 5.103

8.  Persistent reovirus infection of CHO cells resulting in virus resistance.

Authors:  R Taber; V Alexander; W Whitford
Journal:  J Virol       Date:  1976-02       Impact factor: 5.103

9.  Viruses as an aid to cancer therapy: regression of solid and ascites tumors in rodents after treatment with bovine enterovirus.

Authors:  M W Taylor; B Cordell; M Souhrada; S Prather
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

10.  Accelerated Cytopathology in HeLa Cells Induced by Reovirus and Cycloheximide.

Authors:  P C Loh; H K Oie; R M Ratnayake
Journal:  Infect Immun       Date:  1970-12       Impact factor: 3.441

View more
  56 in total

1.  Reovirus as a novel oncolytic agent.

Authors:  K L Norman; P W Lee
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

2.  Personalized medicine in metastatic non-small-cell lung cancer: promising targets and current clinical trials.

Authors:  A Black; D Morris
Journal:  Curr Oncol       Date:  2012-06       Impact factor: 3.677

3.  Reovirus-induced apoptosis requires activation of transcription factor NF-kappaB.

Authors:  J L Connolly; S E Rodgers; P Clarke; D W Ballard; L D Kerr; K L Tyler; T S Dermody
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

4.  Reovirus variants with mutations in genome segments S1 and L2 exhibit enhanced virion infectivity and superior oncolysis.

Authors:  Maya Shmulevitz; Shashi A Gujar; Dae-Gyun Ahn; Adil Mohamed; Patrick W K Lee
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

5.  The viral tropism of two distinct oncolytic viruses, reovirus and myxoma virus, is modulated by cellular tumor suppressor gene status.

Authors:  M Kim; C T Williamson; J Prudhomme; D G Bebb; K Riabowol; P W K Lee; S P Lees-Miller; Y Mori; M M Rahman; G McFadden; R N Johnston
Journal:  Oncogene       Date:  2010-05-17       Impact factor: 9.867

6.  Identification of an NF-kappaB-dependent gene network in cells infected by mammalian reovirus.

Authors:  Sean M O'Donnell; Geoffrey H Holm; Janene M Pierce; Bing Tian; Melissa J Watson; Ravi S Chari; Dean W Ballard; Allan R Brasier; Terence S Dermody
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

7.  Serotonin Receptor Agonist 5-Nonyloxytryptamine Alters the Kinetics of Reovirus Cell Entry.

Authors:  Bernardo A Mainou; Alison W Ashbrook; Everett Clinton Smith; Daniel C Dorset; Mark R Denison; Terence S Dermody
Journal:  J Virol       Date:  2015-06-24       Impact factor: 5.103

8.  The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus.

Authors:  J E Strong; M C Coffey; D Tang; P Sabinin; P W Lee
Journal:  EMBO J       Date:  1998-06-15       Impact factor: 11.598

9.  Synergistic antitumor activity of oncolytic reovirus and chemotherapeutic agents in non-small cell lung cancer cells.

Authors:  Shizuko Sei; Jodie K Mussio; Quan-en Yang; Kunio Nagashima; Ralph E Parchment; Matthew C Coffey; Robert H Shoemaker; Joseph E Tomaszewski
Journal:  Mol Cancer       Date:  2009-07-14       Impact factor: 27.401

10.  Reovirus oncolysis: the Ras/RalGEF/p38 pathway dictates host cell permissiveness to reovirus infection.

Authors:  Kara L Norman; Kensuke Hirasawa; An-Dao Yang; Michael A Shields; Patrick W K Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.